Journal DOI 10.68956/journal.parenting

← Trust · 20 readings

Parenting Journal · Volume 5 · Issue 2 · Licensed source edition

Artificial intelligence–enabled nursing surveillance for pediatric cancer immunotherapy: integrating biomarkers, patient-reported outcomes, and long-term toxicity management

Originally published 2026-10-16 · Frontiers in Medicine
Frontiers Media SA · DOI 10.3389/fmed.2026.1976674 ↗

TrustEvidence reviewCC BY 4.0
Ask this paper · Find source passages →

Editorial reading guide · Trust

What does this 2026 research add to our understanding of ai, technology & human agency?

This 2026 evidence review was selected for “AI, Technology & Human Agency” because its stated focus contributes to ai, technology & human agency. The original abstract begins: Pediatric cancer immunotherapy has expanded from anti-GD2 antibodies and bispecific T-cell engagers to immune checkpoint inhibitors and chimeric antigen receptor T-cell

Study context

Population and setting described by the source: Pediatric cancer immunotherapy has expanded from anti-GD2 antibodies and bispecific T-cell engagers to immune checkpoint inhibitors and chimeric antigen receptor T-cell

Age / stage: Childhood; Parents and caregivers

Read with three questions

  1. What question does “Artificial intelligence–enabled nursing surveillance for pediatric cancer immunotherapy: integrating biomarkers, patient-reported outcomes, and long-term toxicity management” investigate, and what does it report?
  2. Which participants, measures, setting and follow-up shape the evidence?
  3. What should be checked before carrying the finding into another family, school or community?

Keep the limits in view

This evidence review should be interpreted within its reported population, measures, setting and follow-up. One article cannot establish what every family should do, and the issue placement is an editorial reading path rather than a claim that the source authors tested or endorsed TRICK.

The text below is the original article’s licensed repository edition. Its wording is not rewritten. Use the Paper Agent beside the text to locate evidence; open the source for figures, tables and complete context.

Opening the verified paper and agent…

Checking the article identity, license record, and saved source text.

Open the repository record

Attribution & reuse

Follow the original.

Original authorship, publication date, journal and DOI are preserved. This issue’s TRICK placement and reading questions are editorial additions, not claims made by the original authors.

Yi Peng; Qiong Kou; Sihong Guo; Jia Xu; Lijuan Wang; Xiaoyan Chen (2026). Artificial intelligence–enabled nursing surveillance for pediatric cancer immunotherapy: integrating biomarkers, patient-reported outcomes, and long-term toxicity management Frontiers in Medicine. https://doi.org/10.3389/fmed.2026.1976674

Permissions checked against the saved article notice; repository publication notices screened 2026-11-12. This is not a new peer-review decision. The source authors and publishers are not represented as endorsing this issue.